Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy
Hammer SS, Dorweiler TF, McFarland D, et al.
Diabetologia. Pub. online 14 Jun 2023.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial
Pieber TR, Arfelt KN, Cailleteau R, et al.
Diabetologia. Pub. online 13 Jun 2023.
Leggi
Diabetes, fasting blood glucose and the efficacy of remote ischaemic conditioning: a secondary analysis of the RICAMIS trial
Zhang YN, Dai YJ, Cui Y, et al.
Diabetes Obes Metab. Pub. online 8 Jun 2023.
Leggi
Evaluation of the effects of ezetimibe on albuminuria and kidney fat in individuals with type 2 diabetes and chronic kidney disease
Heinrich NS, Pedersen RP, Vestergaard MB, et al.
Diabetes Obes Metab. Pub. online 6 Jun 2023.
Leggi
The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes
Ceriello A, Lucisano G, Prattichizzo F, La Grotta R, Frigé C, De Cosmo S, Di Bartolo P, Di Cianni G, Fioretto P, Giorda CB, Pontremoli R, Russo G, Viazzi F, Nicolucci A
The Lancet Regional Health-Europe. Pub. online 12 Jun 2023.
Leggi
Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1b, multicentre, blinded, placebo‐controlled, randomized, multiple‐ascending‐dose study in people with type 2 diabetes
Pratt E, Ma X, Liu R, et al.
Diabetes Obes Metab. Pub. online 1 Jun 2023.
Leggi
Genetic evidence that high BMI in childhood has a protective effect on intermediate diabetes traits, including measures of insulin sensitivity and secretion, after accounting for BMI in adulthood
Hawkes G, Beaumont RN, Tyrrell J, et al.
Diabetologia. Pub. online 6 Jun 2023.
Leggi
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in Diabetic patients with Acute Myocardial Infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT Registry
Paolisso P, Bergamaschi L, Cesaro A, et al.
Diabetes Res Clin Pract. 2023;110766.
Leggi
Incidence of diabetes mellitus in patients treated with immune checkpoint inhibitors (ICI) therapy – a comprehensive cancer center experience
Zhang Z, Sharma R, Hamad LA, et al.
Diabetes Res Clin Pract. Pub. online 10 Jan 2023.
Leggi
The Type 1 Diabetes and EXercise Initiative (T1DEXI): predicting hypoglycemia risk during exercise for participants with type 1 diabetes using repeated measures random forest
Bergford S, Riddell MC, Jacobs PG, et al.
Diabetes Technol Ther. Pub. online 9 Jun 2023.
Leggi